Stay updated on IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial
Sign up to get notified when there's something new on the IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial page.

Latest updates to the IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new revision entry v3.5.0 was added to the history and the previous entry v3.4.3 was removed.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe history now includes Revision: v3.4.3 and removes Revision: v3.4.2 from the page's history.SummaryDifference0.1%

- Check41 days agoChange DetectedNew entries were added to the record history: 'Study Status' on 2026-02-13 and a value '43' on 2026-02-12, with a deletion recorded on 2025-12-17.SummaryDifference0.2%

- Check48 days agoChange DetectedThe record history now includes a new revision entry: v3.4.2. The previous revision v3.4.1 has been removed from the listing.SummaryDifference0.1%

- Check55 days agoChange DetectedThe history shows a new revision entry (v3.4.1) and removal of the previous v3.4.0 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 with no substantive changes to page content or study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial page.